Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
Purity | ≥98% |
---|---|
Formula | C25H39H7O8 |
Formula Wt. | 565.63 |
Synonym | EHIPA. |
Solubility | Soluble in water (2 mg/mL). |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
Thrombin substrate used to measure thrombin act...
Aromatic acridine derivative, DNA intercalator....
Calcitonin-family peptide, involved in vasodila...
Notch inhibitor.
PKA and PDK1 inhibitor, HCN channel blocker, po...
Peptide; PAR1 agonist.
Endogenous tachykinin peptide, involved in infl...
Aurora kinase A inhibitor
V2 antagonist.
PKD inhibitor.
JAK3 inhibitor.
Flavonoid found in Epimedium.
AurKA inhibitor.
Alkaloid compound originally found in Corydalis...
Peptide, binds heparin.
Mycotoxin; F1F0 ATP synthase inhibitor.
Piroxicam prodrug, NSAID; COX-1/2 inhibitor.
Thiopurine antimetabolite; PRPP amidotransferas...
Macrolide; protein translation inhibitor, mamma...
Sulfonylurea; ATP-sensitive K+ channel blocker....